increased susceptibility to experimental autoimmune encephalomyelitis_Nr3c1<tm2.1Gsc>/Nr3c1<+>

http://metadb.riken.jp/0004799B6129P2Nr3c1tm21GscNr3c1tm21GscNr3c1Nr3c1tm21GscNr3c1

increased susceptibility to experimental autoimmune encephalomyelitis_Nr3c1<tm2.1Gsc>/Nr3c1<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• nuclear receptor subfamily 3, group C, member 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:95824

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Nr3c1<tm2.1Gsc>/Nr3c1<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Nr3c1<tm2.1Gsc>|Nr3c1<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.129P2-Nr3c1<tm2.1Gsc>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased susceptibility to experimental autoimmune encephalomyelitis
  http://purl.obolibrary.org/obo/MP_0004799

文献

http://purl.org/net/cito/citesAsAuthority

• Simone. Wüst, et.al., Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis., Journal of immunology (Baltimore, Md. : 1950), 2008, 180
  http://rdf.ncbi.nlm.nih.gov/pubmed/18523311